[{"Assets_0_Q3_USD":127948000.0,"CommonStockSharesOutstanding_0_Q3_shares":48772716.0,"NetIncomeLoss_3_Q3_USD":-21796000.0,"NetIncomeLoss_1_Q3_USD":-6560000.0,"StockholdersEquity_0_Q3_USD":37297000.0,"Ticker":"CCXI","CIK":"1340652","name":"CHEMOCENTRYX, INC.","OfficialName":"ChemoCentryx Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1508212562.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20171107"}]